[Topical tacrolimus in dermatology: what can one expect?].
Lacour
J P
JP
D000287:Administration, Topical; D000328:Adult; D016907:Adverse Drug Reaction Reporting Systems; D000818:Animals; D001327:Autoimmune Diseases / Q000188:drug therapy*; D002648:Child; D002986:Clinical Trials as Topic; D003876:Dermatitis, Atopic / Q000188:drug therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage* / Q000009:adverse effects; D012871:Skin Diseases / Q000188:drug therapy*; D016559:Tacrolimus / Q000008:administration & dosage* / Q000009:adverse effects; D016896:Treatment Outcome
D007166:Immunosuppressive Agents; D016559:Tacrolimus